FDA inspection
Celgene Corp., d.b.a. Abraxis BioScience LLC: FDA inspection ending Feb 8, 2010
FDA inspection 644313 · No Action Indicated (NAI) · Melrose Park, IL
Key facts
| Inspection ID | 644313 |
|---|---|
| Firm | Celgene Corp., d.b.a. Abraxis BioScience LLC |
| FEI number | 3006814961 |
| Address | 2020 N Ruby St |
| City | Melrose Park |
| State | IL |
| ZIP | 60160 |
| Country | United States |
| Fiscal year | 2010 |
| Inspection end date | Feb 8, 2010 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data